Cell-free DNA screening
for trisomy 13, 18 and 21

Laboratoire Cerba makes available on its website: www.trisomie21-foetale.com medical information to healthcare professionals and patients willing to get information about the new non-invasive genetic test for fetal trisomy 21 for pregnant women belonging to a group at risk, a test that Laboratoire Cerba is the only one to perform in France on its technical platform .
Information that may be collected from visitors to the website are confidential. Laboratoire Cerba hereby undertakes to respect the legal confidentiality conditions applicable and to not disclose this information.
Our website collects non-personal data through cookies generated and stored by each visitor.
Those cookies are used for statistical purposes only, in order to analyze the website's audience and to improve its content. For more information on privacy policies and on the use of the "Google Analytics " application, please click here: http://www.google.com/intl/fr/analytics/privacyoverview.html

Director of publication

Pascale LAURENT – Head of Marketing & Communication at Laboratoire Cerba and Cerba HealthCare group

Website design

ANSWEB agency specialized in digital – SAS with a capital of 38 250 € - R.C. 1999b1205 – Intracommunity VAT N° FR23424705903
Photo credits: purchase of pictures on istockphoto.

Hosting

Risc Group IT Solutions
Commercial name: Navaho
SA
Tel : +33 1 46 20 92 00

Headquarters:
10 RUE WALDECK ROCHET BATIMENT 521
CS 80001
93308 AUBERVILLIERS CEDEX - France

CEO: Pierre Fort
Director of publication: Benoit Huard

Intellectual Property

The content of trisomie21.lab-cerba.com website is protected by the laws in force in France regarding intellectual property, including copyright , neighboring rights , trademark law, right to the image and by international regulation.
Therefore, any total or partial reproduction of this website and its contents by any means, without the express prior authorization of Laboratoire Cerba is prohibited and would constitute an infringement prohibited, amoust others, by the articles L335- 2 and following of the Code of intellectual Property .

Modification of webite

Laboratoire Cerba has the right to modify or correct the content of the website as well as those terms of use any time and without prior notice.

Disclaimer

It is the user 's responsibility to take all appropriate measures to protect its own data and / or software against viruses circulating on the Internet.

Medical Information

The www.trisomy21.lab - cerba.com website provides patients and healthcare professionals with medical information (not exhaustive) about the non -invasive test for fetal trisomy 21 and other aneuploidies , which in no case can replace a medical consultation.

Hypertext links and other websites

Laboratoire Cerba Cerba has no control over the content of third party websites. The existence of a hypertext link between t21.lab - cerba.com and another website means in no way the control of the third party’s website.

CNIL (Commission Nationale Informatique et Libertés)

The website has been declared to the Commission Nationale Informatique et Libertés (CNIL).
In agreement with the Articles 39 and following of the law n ° 78-17 of January the 6th, 1978 amended in 2004 relating to data, files and freedom, every person can obtain the communication and , if necessary , the rectification or deletion of the information related to him/her by contacting the Medical Information Desk of Laboratoire Cerba, either by phone at ( +33) .1.34.40.20.20 or by e- mail: This email address is being protected from spambots. You need JavaScript enabled to view it. or by regular mail.

 


Print Top of page
11
09
2016

More than 25 000 tests

To date, more than 25 000 pregnant women received a...

Read more
04
07
2016

More than 9.600 tests

To date, more than 9.600 pregnant women from entire France...

Read more

Agenda

Scientific evening

December 2018
M T W T F S S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31